Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan + amoxicillin dual therapy for initial Helicobacter pylori eradication
ChiCTR2400092387Phase 4Not yet recruiting
- Sponsor
- Hangzhou Third People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tegoprazan and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Hangzhou Third People's Hospital. Primary endpoint: Helicobacter pylori eradication rate. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
tegoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400092387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092387.